Buenavista acquires 71.2% stake in Tiryaq Medical Group

Buenavista Equity Partners agreed to acquire 71.2% of Madrid-based Tiryaq Medical Group on October 15, 2026. The transaction combines a share purchase with a capital increase to fund expansion of the specialist healthcare group. Expansion plans include extending the clinical network into other Spanish regions through organic growth and complementary acquisitions. Founder Dr. Ghassan Elgeadi Saleh will continue leading Tiryaq, which specializes in orthopedics, minimally invasive surgery and regenerative medicine. Tiryaq generates annual revenue of EUR 13 million and performs more than 5,000 surgical procedures a year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Buenavista Equity Partners SL published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein. (C)